Brewin Dolphin LTD Spero Therapeutics, Inc. Transaction History

Brewin Dolphin LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2023	SELL	$8.96 - $14.12 $1,881 - $2,965	-210 Reduced 30.52%	478 $5.33 Million
Q1 2020 Nov 09, 2023	BUY	$5.27 - $10.41 $474 - $936	90 Added 15.05%	688 $5.56 Million
Q2 2019 Nov 09, 2023	BUY	$10.25 - $14.36 $1,568 - $2,197	153 Added 34.38%	598 $6.88 Million
Q3 2018 Nov 09, 2023	BUY	$9.69 - $17.79 $4,312 - $7,916	445 New	445 $4.68 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.